FDA NDA · NDA019138

ALPHATREX

Sponsor: SAVAGE LABS

APPLICATION

NDA019138

TYPE

NDA

ORIGINAL APPROVAL

1984-06-26

LATEST ACTION

1996-11-01

ROUTE

TOPICAL

DOSAGE FORM

CREAM

MARKETING STATUS

Discontinued

Products

ALPHATREXDiscontinued

BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · CREAM · TOPICAL

1996-11-01Labeling · Supplement 10AP

1996-03-07Manufacturing (CMC) · Supplement 11AP

1988-10-31Manufacturing (CMC) · Supplement 8AP

1988-10-31Manufacturing (CMC) · Supplement 9AP

1988-10-31Manufacturing (CMC) · Supplement 7AP

1987-04-23Manufacturing (CMC) · Supplement 6AP

1986-03-28Manufacturing (CMC) · Supplement 1AP

1986-03-18Manufacturing (CMC) · Supplement 2AP

1984-06-26OriginalAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.